A. ÇAYIR Et Al. , "The Lung Endothelin System a Potent TherapeuticTarget with Bosentan for the Amelioration of LungAlterations in a Rat Model of Diabetes Mellitus," 53rd Annual Meetingof the European Society forPaediatric Endocrinology (ESPE) , 2014
ÇAYIR, A. Et Al. 2014. The Lung Endothelin System a Potent TherapeuticTarget with Bosentan for the Amelioration of LungAlterations in a Rat Model of Diabetes Mellitus. 53rd Annual Meetingof the European Society forPaediatric Endocrinology (ESPE) .
ÇAYIR, A., HALICI, Z., AKPINAR, E., BAYRAKTUTAN, Z., & KARA, M., (2014). The Lung Endothelin System a Potent TherapeuticTarget with Bosentan for the Amelioration of LungAlterations in a Rat Model of Diabetes Mellitus . 53rd Annual Meetingof the European Society forPaediatric Endocrinology (ESPE)
ÇAYIR, ATİLLA Et Al. "The Lung Endothelin System a Potent TherapeuticTarget with Bosentan for the Amelioration of LungAlterations in a Rat Model of Diabetes Mellitus," 53rd Annual Meetingof the European Society forPaediatric Endocrinology (ESPE), 2014
ÇAYIR, ATİLLA Et Al. "The Lung Endothelin System a Potent TherapeuticTarget with Bosentan for the Amelioration of LungAlterations in a Rat Model of Diabetes Mellitus." 53rd Annual Meetingof the European Society forPaediatric Endocrinology (ESPE) , 2014
ÇAYIR, A. Et Al. (2014) . "The Lung Endothelin System a Potent TherapeuticTarget with Bosentan for the Amelioration of LungAlterations in a Rat Model of Diabetes Mellitus." 53rd Annual Meetingof the European Society forPaediatric Endocrinology (ESPE) .
@conferencepaper{conferencepaper, author={ATİLLA ÇAYIR Et Al. }, title={The Lung Endothelin System a Potent TherapeuticTarget with Bosentan for the Amelioration of LungAlterations in a Rat Model of Diabetes Mellitus}, congress name={53rd Annual Meetingof the European Society forPaediatric Endocrinology (ESPE)}, city={}, country={}, year={2014}}